Home > Insider Trading > Filing (0001181431-12-042507)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1327111	Lynn Seely	C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-07-25	2,400	$34.56	23,911	No	4	M	Direct
Common Stock	Disposition	2012-07-25	2,400	$98.01	21,511	No	4	S	Direct
Common Stock	Acquisiton	2012-07-26	37,600	$34.56	59,111	No	4	M	Direct
Common Stock	Disposition	2012-07-26	32,094	$99.64	27,017	No	4	S	Direct
Common Stock	Disposition	2012-07-26	5,506	$100.27	21,511	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-07-25	2,400	$0.00	2,400	$34.56
Common Stock	Stock Option (Right to Buy)	Disposition	2011-07-26	37,600	$0.00	37,600	$34.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
91,600		2019-12-15	No	4	M	Direct
54,000		2019-12-15	No	4	M	Direct

Footnotes

Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $98.00 to $98.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares subject to the option vest according to the following schedule: 25% of the shares subject to the option (rounded down to the next whole number of shares) vested on December 15, 2012, and 1/48th of the shares subject to the option (rounded down to the next whole number of shares) vest of the first day of each full month thereafter.
The shares were sold at prices ranging from $98.99 to $99.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $99.99 to $100.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.